By Victor Vybz | Gwinnett News Report
LAWRENCEVILLE, Ga. — Gwinnett County leaders have announced a historic economic development milestone. Global biopharmaceutical company UCB has chosen the county’s expanding Rowen knowledge community. This site will host its first United States biologics manufacturing facility.
The project signifies a $2 billion investment. It is the largest capital investment in Gwinnett County’s history. It also positions the region as a rising hub for advanced manufacturing, life sciences, and global innovation.
UCB is a biopharmaceutical company based in Belgium with its headquarters in Brussels. It specializes in developing treatments for individuals with severe neurological and autoimmune conditions. The decision to set up a major presence in Gwinnett follows a competitive, multi-state site choice process.
County officials say the investment is expected to generate long-term economic benefits. This includes more than 330 permanent jobs with an average annual salary exceeding $72,000. Additionally, there will be over 1,000 construction jobs during the development phase. In total, the project is projected to deliver an estimated $5 billion economic impact over time.
The new facility will be located on approximately 79 acres within the Rowen development. It is a 2,000-acre innovation district along Georgia’s Highway 316 corridor. The planned 460,000-square-foot facility will incorporate cutting-edge technologies. These include artificial intelligence, robotics, and advanced automation. The facility will emphasize sustainability and efficient use of natural resources.
Gwinnett County Board of Commissioners Chairwoman Nicole Love Hendrickson described the announcement as a transformational moment for the region.
“We are thrilled that UCB has chosen Gwinnett County to advance its global operations and pioneering innovations,” Hendrickson said. “An investment of this size reflects our commitment to building a center for collaboration, discovery and long-term economic growth.”
District 3 Commissioner Jasper Watkins III also emphasized the broader impact of the project, particularly in healthcare innovation.
“This investment signifies a significant step ahead for Gwinnett County,” Watkins said. “It strengthens our pharmaceutical capabilities. It highlights the strength of our workforce. Our community is committed to innovation and improved health outcomes.”
Gwinnett County has committed more than $174 million in incentives. These incentives include property tax savings, fee waivers, and infrastructure investments. This support aims to help the project and guarantee its long-term success.
The development of Rowen has been years in the making. The project was first announced in 2020. It was envisioned as a collaborative ecosystem. Researchers, global companies, and entrepreneurs can work together here. They aim to solve complex global challenges. UCB’s decision is seen as a major step toward bringing that vision to life.
Infrastructure improvements for the Rowen development include new water and sewer lines. They also feature expanded roadways and trail systems. Additionally, there will be a regional sewer pump station. County officials say these upgrades are critical to attracting high-level investment and supporting future growth.
Rowen is preparing to launch its Convergence Center. This move further solidifies the area as a destination for research, innovation, and advanced industry.
Economic development leaders claim that UCB’s investment sends a strong message to companies worldwide. This message indicates that Gwinnett County is ready to compete on a global stage.
“This project demonstrates that Gwinnett is not only open for business but is actively shaping the future of advanced manufacturing and life sciences,” officials noted.
As construction begins, the project will accelerate Gwinnett’s transformation into a leading center for innovation. It will create new opportunities for residents. The project will also strengthen the county’s economic foundation for years to come.
Leave a Reply